在英国肠道癌症筛查计划中实施光学诊断联合「切除并丢弃」策略的经济影响:DISCARD3研究结果
本研究基于DISCARD3研究构建决策树,比较光学诊断联合「切除并丢弃」策略与标准组织病理学检查对≤5 mm和6-9 mm结直肠息肉患者的经济影响,并外推至英国肠道癌症筛查计划全国队列。结果显示该策略可大幅降低直接医疗成本且监测间期一致性不受不利影响。
要点
- 在DISCARD3研究的525例患者中,354例被评估监测间期(排除结直肠癌和至少1枚息肉>10 mm的病例)。
- 354例中269例有息肉,其中182例仅有微小息肉,77例同时有小息肉和微小息肉,10例仅有小息肉。
- 至少1枚微小息肉患者的监测间期一致性为97.9%,至少1枚微小或小息肉患者为98.7%。
核心结论
- 在肠道癌症筛查计划结肠镜检查中,对微小和小息肉采用光学诊断联合「切除并丢弃」策略可大幅节省成本,且未对监测间期一致性产生不利影响。
研究设计与样本
- 基于DISCARD3研究(Detect InSpect ChAracterise Resect and Discard 3)构建决策树,比较「切除并丢弃」策略与标准组织病理学检查,并外推至英国肠道癌症筛查计划全国患者队列。
主要发现
- DISCARD3研究中,「切除并丢弃」策略使微小息肉患者的直接医疗总成本降低44,285.63美元(-72.3%),使微小或小息肉患者降低66,129.13美元(-75.0%)。
- 至少1枚微小息肉患者的监测间期一致性为97.9%,至少1枚微小或小息肉患者为98.7%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Advances in endoscopic technology, such as narrow-band imaging and high-definition colonoscopes, offer the potential for optical diagnosis (OD) with a "resect and discard" (RD) strategy for diminutive (≤5 mm) and small (6-9 mm) colorectal polyps. This could help alleviate the huge cost and time burden required for histopathology. The aim of this study was to conduct an economic analysis of an RD strategy within the English Bowel Cancer Screening Programme (BCSP). METHODS: A decision tree was designed to compare an RD strategy with standard histopathology for patients included in the DISCARD3 study (Detect InSpect ChAracterise Resect and Discard 3) and was extrapolated to a national BCSP patient cohort. RESULTS: Of the 525 patients in the DISCARD3 study, 354 were assessed for surveillance intervals (after excluding cases with colorectal cancer and at least 1 polyp >10 mm). Of 354 patients, 269 had polyps, of which 182 had only diminutive polyps, 77 had both small and diminutive polyps, and 10 had only small polyps. Surveillance interval concordance was 97.9% in patients with at least 1 diminutive polyp and 98.7% in patients with at least 1 diminutive or small polyp. In DISCARD3, an RD approach was found to reduce overall direct healthcare costs by $44,285.63 (-72.3%) for patients with diminutive polyps or by $66,129.13 (-75.0%) for patients with diminutive or small polyps. When extrapolated to the entire English BCSP, the annual savings were almost $3 million for patients with diminutive polyps or $4.3 million for patients with diminutive or small polyps, after adjusting for the costs of an OD quality assurance process. CONCLUSIONS: OD with an RD strategy for diminutive and small polyps during BCSP colonoscopy would offer substantial cost savings without adversely affecting surveillance interval concordance.
引用
- Orlovic M, Ahmad A, Saunders BP, et al. Economic impact of implementing optical diagnosis with a "resect and discard" strategy within the English Bowel Cancer Screening Programme: findings from the DISCARD3 study. Gastrointest Endosc. 2023. PMID: 36739996. doi:10.1016/j.gie.2023.01.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。